MD
Mika K Derynck (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $9.6M of ELVN (158,795 sh × $60.21, as filed), executed Aug 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.6M
shares × price, as filed
Last traded
Aug 4
Filed Aug 6
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$9.6M158,795 sh × $60.21
Exec Aug 4
Filed Aug 6 · 8:18 PM ET